37 related articles for article (PubMed ID: 38629735)
1. Receptor Ligand-Free Mesoporous Silica Nanoparticles: A Streamlined Strategy for Targeted Drug Delivery across the Blood-Brain Barrier.
Chen ZA; Wu CH; Wu SH; Huang CY; Mou CY; Wei KC; Yen Y; Chien IT; Runa S; Chen YP; Chen P
ACS Nano; 2024 May; 18(20):12716-12736. PubMed ID: 38718220
[TBL] [Abstract][Full Text] [Related]
2. VEGF-mediated tight junctions pathological fenestration enhances doxorubicin-loaded glycolipid-like nanoparticles traversing BBB for glioblastoma-targeting therapy.
Wen L; Tan Y; Dai S; Zhu Y; Meng T; Yang X; Liu Y; Liu X; Yuan H; Hu F
Drug Deliv; 2017 Nov; 24(1):1843-1855. PubMed ID: 29182025
[TBL] [Abstract][Full Text] [Related]
3. All-stage targeted red blood cell membrane-coated docetaxel nanocrystals for glioma treatment.
Ding Y; Xu Q; Chai Z; Wu S; Xu W; Wang J; Zhou J; Luo Z; Liu Y; Xie C; Lu L; Lu W
J Control Release; 2024 May; 369():325-334. PubMed ID: 38565395
[TBL] [Abstract][Full Text] [Related]
4. Study of the anti-cancer activity of a mesoporous silica nanoparticle surface coated with polydopamine loaded with umbelliprenin.
Edalatian Tavakoli S; Motavalizadehkakhky A; Homayouni Tabrizi M; Mehrzad J; Zhiani R
Sci Rep; 2024 May; 14(1):11450. PubMed ID: 38769394
[TBL] [Abstract][Full Text] [Related]
5. Targeting brain tumors with innovative nanocarriers: bridging the gap through the blood-brain barrier.
Wadhwa K; Chauhan P; Kumar S; Pahwa R; Verma R; Goyal R; Singh G; Sharma A; Rao N; Kaushik D
Oncol Res; 2024; 32(5):877-897. PubMed ID: 38686045
[TBL] [Abstract][Full Text] [Related]
6. Functionalized liposomes: an enticing nanocarrier for management of glioma.
Peddinti V; Rout B; Agnihotri TG; Gomte SS; Jain A
J Liposome Res; 2024 Jun; 34(2):349-367. PubMed ID: 37855432
[TBL] [Abstract][Full Text] [Related]
7. Ultrasmall iron oxide nanoparticles with MRgFUS for enhanced magnetic resonance imaging of orthotopic glioblastoma.
Chen J; Yang R; Yu H; Wu H; Wu N; Wang S; Yin X; Shi X; Wang H
J Mater Chem B; 2024 May; 12(20):4833-4842. PubMed ID: 38647018
[TBL] [Abstract][Full Text] [Related]
8. A blood-brain barrier- and blood-brain tumor barrier-penetrating siRNA delivery system targeting gliomas for brain tumor immunotherapy.
Tang L; Zhang R; Wang Y; Liu M; Hu D; Wang Y; Yang L
J Control Release; 2024 May; 369():642-657. PubMed ID: 38575072
[TBL] [Abstract][Full Text] [Related]
9. Continuous iontronic chemotherapy reduces brain tumor growth in embryonic avian in vivo models.
Handl V; Waldherr L; Arbring Sjöström T; Abrahamsson T; Seitanidou M; Erschen S; Gorischek A; Bernacka-Wojcik I; Saarela H; Tomin T; Honeder SE; Distl J; Huber W; Asslaber M; Birner-Grünberger R; Schäfer U; Berggren M; Schindl R; Patz S; Simon DT; Ghaffari-Tabrizi-Wizsy N
J Control Release; 2024 May; 369():668-683. PubMed ID: 38548064
[TBL] [Abstract][Full Text] [Related]
10. Integrative Chinese-Western medicine strategy to overcome docetaxel resistance in prostate cancer.
Chen L; Xu YX; Wang YS; Ren YY; Chen YM; Zheng C; Xie T; Jia YJ; Zhou JL
J Ethnopharmacol; 2024 Sep; 331():118265. PubMed ID: 38677579
[TBL] [Abstract][Full Text] [Related]
11. Strategies to Improve Drug Delivery Across the Blood-Brain Barrier for Glioblastoma.
Narsinh KH; Perez E; Haddad AF; Young JS; Savastano L; Villanueva-Meyer JE; Winkler E; de Groot J
Curr Neurol Neurosci Rep; 2024 May; 24(5):123-139. PubMed ID: 38578405
[TBL] [Abstract][Full Text] [Related]
12. Boosting antitumor efficacy using docetaxel-loaded nanoplatforms: from cancer therapy to regenerative medicine approaches.
Beheshtizadeh N; Amiri Z; Tabatabaei SZ; Seraji AA; Gharibshahian M; Nadi A; Saeinasab M; Sefat F; Kolahi Azar H
J Transl Med; 2024 May; 22(1):520. PubMed ID: 38816723
[TBL] [Abstract][Full Text] [Related]
13. Cancer cell membrane-camouflaged biomimetic nanoparticles for enhancing chemo-radiation therapy efficacy in glioma.
Tang C; Wang Y; Wu M; Wang Z; Zhou Y; Lin Y; Wang Y; Xu H
J Biomed Res; 2024 May; ():1-16. PubMed ID: 38812286
[TBL] [Abstract][Full Text] [Related]
14. Overcoming the Blood-Brain Tumor Barrier with Docetaxel-Loaded Mesoporous Silica Nanoparticles for Treatment of Temozolomide-Resistant Glioblastoma.
Hsu TI; Chen YP; Zhang RL; Chen ZA; Wu CH; Chang WC; Mou CY; Chan HW; Wu SH
ACS Appl Mater Interfaces; 2024 May; 16(17):21722-21735. PubMed ID: 38629735
[TBL] [Abstract][Full Text] [Related]
15. Development of a hybrid nanocarrier-recognizing tumor vasculature and penetrating the BBB for glioblastoma multi-targeting therapy.
Fan R; Chuan D; Hou H; Chen H; Han B; Zhang X; Zhou L; Tong A; Xu J; Guo G
Nanoscale; 2019 Jun; 11(23):11285-11304. PubMed ID: 31165845
[TBL] [Abstract][Full Text] [Related]
16. Intranasal Delivery of Temozolomide-Conjugated Gold Nanoparticles Functionalized with Anti-EphA3 for Glioblastoma Targeting.
Wang L; Tang S; Yu Y; Lv Y; Wang A; Yan X; Li N; Sha C; Sun K; Li Y
Mol Pharm; 2021 Mar; 18(3):915-927. PubMed ID: 33417456
[TBL] [Abstract][Full Text] [Related]
17. Efficient delivery of Temozolomide using ultrasmall large-pore silica nanoparticles for glioblastoma.
Janjua TI; Cao Y; Ahmed-Cox A; Raza A; Moniruzzaman M; Akhter DT; Fletcher NL; Kavallaris M; Thurecht KJ; Popat A
J Control Release; 2023 May; 357():161-174. PubMed ID: 36965857
[TBL] [Abstract][Full Text] [Related]
18. Involvement of Intracellular Cholesterol in Temozolomide-Induced Glioblastoma Cell Death.
Yamamoto Y; Sasaki N; Kumagai K; Takeuchi S; Toyooka T; Otani N; Wada K; Narita Y; Ichimura K; Namba H; Mori K; Tomiyama A
Neurol Med Chir (Tokyo); 2018 Jul; 58(7):296-302. PubMed ID: 29899179
[TBL] [Abstract][Full Text] [Related]
19. Improving temozolomide biopharmaceutical properties in glioblastoma multiforme (GBM) treatment using GBM-targeting nanocarriers.
Delello Di Filippo L; Hofstätter Azambuja J; Paes Dutra JA; Tavares Luiz M; Lobato Duarte J; Nicoleti LR; Olalla Saad ST; Chorilli M
Eur J Pharm Biopharm; 2021 Nov; 168():76-89. PubMed ID: 34461214
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
